Key result
In elderly patients with heart failure, CRT-D was associated with similar survival compared to CRT-P in a propensity score-matched cohort (P=0.91).
Why the study?
Does cardiac resynchronization therapy with a defibrillator (CRT-D) reduce mortality and cardiac hospitalisation compared to CRT without a defibrillator (CRT-P) in elderly patients with heart failure?
Population
170 elderly patients with heart failure who received CRT implantation, median age 79, 83% male, treated at a…
Comparison
Cardiac resynchronization therapy with a… vs Cardiac resynchronization therapy without a…
Design
Cohort
Follow-up
3 years
Authors
Loading...
No survival difference supports cautious CRT-D selection in elderly HF; leaves open need for randomized confirmation.
Cohort (n=170)
No
Does cardiac resynchronization therapy with a defibrillator (CRT-D) reduce mortality and cardiac hospitalisation compared to CRT without a defibrillator (CRT-P) in elderly patients with heart failure?
p-value: p=0.91
In elderly patients (≥75 years) with heart failure, CRT-D does not appear to offer a significant survival or hospitalization benefit over CRT-P.
Christie et al. (2018) conducted a cohort in heart failure (n=170). Cardiac resynchronization therapy with a defibrillator (CRT-D) vs. Cardiac resynchronization therapy without a defibrillator (CRT-P) was evaluated on Mortality and time to first cardiac hospitalisation (p=0.91). In elderly patients with heart failure, CRT-D was associated with similar survival compared to CRT-P in a propensity score-matched cohort (P=0.91).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: